Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Total Voting Rights

1 Mar 2011 10:24

FOR IMMEDIATE RELEASE Verona Pharma plc (“Verona” or the “Company”) Total Voting Rights Update

1 March 2011 - London, UK - Verona Pharma plc (AIM: VRP), wishes to notify the market of the following:-

The Company's issued share capital consists of 239,906,705 ordinary shares of 0.1 pence each ("Ordinary Shares"), all with voting rights. No shares were held in treasury at the date of this announcement. The total number of current voting rights in the Company is therefore 239,906,705.

The above figure (239,906,705 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.

For more information please contact:

Verona Pharma plc Tel: 020 7863 3300Clive Page, Chairman info@veronapharma.comMichael Walker, CEOEvolution Securities Limited Tel: 020 7071 4300Bobbie Hilliam / Tim Redfern contactus@evosecurities.com/ Patrick Castle College Hill Tel: 020 7457 2020Melanie Toyne Sewell / Gemma Howe verona@thecollegegroup.com

vendor
Date   Source Headline
18th May 20152:36 pmRNSDirector/PDMR Shareholding
13th May 20157:00 amRNS2014 Annual Report and Accounts and Notice of AGM
12th May 20157:00 amPRNFinal Results
5th May 20153:01 pmPRNNotice of Results
14th Apr 20157:00 amPRNPresentation at the Asthma and COPD Conference
23rd Mar 20157:00 amPRNInterim results from new RPL554 trial
3rd Mar 20153:32 pmPRNDirector’s Dealing
3rd Mar 20157:00 amPRNTrading and Development Programme Update
16th Feb 201511:29 amPRNDirector’s Dealing
16th Feb 20157:00 amRNSDirector's Dealing
5th Feb 201510:29 amPRNDirector’s Dealing
30th Jan 20152:46 pmPRNGrant of Share Options
20th Jan 20159:32 amPRNDirector’s Dealing
14th Jan 20157:00 amPRNDirector's Dealing
12th Jan 20157:01 amPRNPresentation at 7th Annual Biotech Showcase™
12th Jan 20157:00 amPRNFirst patients dosed with new formulation of RPL554
17th Dec 20147:00 amPRNCMO appointment & incorporation of Verona Pharma Inc
5th Dec 20149:47 amPRNDirector Dealings
25th Nov 20141:56 pmRNSDirector's Dealing
24th Nov 20147:00 amPRNDr David Ebsworth Appointed as Non-Executive Chairman
11th Nov 201412:12 pmPRNGrant of Share Options
3rd Nov 20147:00 amPRNCF Trust Venture and Innovation Award
30th Sep 20147:00 amPRNAppointment of Biresh Roy as CFO and Board member
29th Sep 20147:00 amPRNNew data supports RPL554 as a potential CF therapy
11th Sep 20147:00 amPRNHalf-yearly Report
9th Sep 20147:00 amPRNERS Presentations
4th Sep 20147:00 amPRNNotice of Results
6th Aug 201411:57 amPRNAppointment of Nominated Adviser and Broker
2nd Jul 201412:48 pmPRNAmendment - Director Shareholding
2nd Jul 20149:35 amPRNDirector Shareholding
23rd Jun 20147:00 amPRNPhase IIa headline results for VRP700
12th Jun 201411:26 amPRNResult of AGM
21st May 20147:00 amPRNPoster Presentation at ATS
19th May 20143:53 pmPRNPosting of Annual Report and AGM Notice
16th May 201411:25 amPRNGrant of Share Options
28th Apr 20147:00 amPRNFinal Results
24th Apr 20147:00 amPRNChange in Registered Office
1st Apr 20147:00 amPRNNotice of Results
27th Mar 201412:27 pmPRNHolding(s) in Company
27th Mar 201412:24 pmPRNHolding(s) in Company
26th Mar 20141:36 pmPRNHolding(s) in Company
26th Mar 20141:35 pmPRNHolding(s) in Company
26th Mar 20141:33 pmPRNHolding(s) in Company
26th Mar 20141:24 pmPRNHolding(s) in Company
24th Mar 20142:12 pmPRNResult of General Meeting
24th Mar 20147:00 amPRNResult of Open Offer
6th Mar 20145:53 pmPRN£13m Equity Issue, £1m Open Offer and Notice of GM
13th Nov 20137:00 amPRNPresentation at Therapeutic Area Partnerships Meeting
30th Oct 20135:36 pmPRNHolding(s) in Company
25th Oct 20137:00 amPRNRPL554 clinical studies published in The Lancet RM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.